Prophylactic Drugs and Cytokine and Leptin Levels in Children With Migraine

Pediatric Neurology

Volumn 41, Issue 4, 2009, Pages 281-287

  Hirfanoglu, Tugba ^a   Serdaroglu, Ayse ^a   Gulbahar, Ozlem ^a   Cansu, Ali ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CYPROHEPTADINE; CYTOKINE; FLUNARIZINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; AMITRIPTYLINE; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CYPROHEPTADINE; CYTOKINES; FEMALE; FLUNARIZINE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; MALE; MIGRAINE DISORDERS; PROPRANOLOL; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69849116044     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.04.019     Document Type: Article

References (52)

1. Mortimer M.J., Kay J., and Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 34 (1992) 1095-1101
2. Raieli V., Raimondo D., Cammalleri R., and Camarda R. Migraine headache in adolescents: a student population-based study in Monreale. Cephalalgia 15 (1995) 5-12
3. Eiland L.S., Jenkins L.S., and Durham S.H. Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother 41 (2007) 1181-1190
4. Hershey A.D., Winner P., Kabbouche M.A., and Powers S.W. Headaches. Curr Opin Pediatr 19 (2007) 663-669
5. Hernandez-Latorre R.M. Natural history of migraine in childhood. Cephalalgia 20 (2000) 573-579
6. Swanson J.W., Dodick D.W., and Capobianco D.J. Headache and other craniofacial pain. In: Bradley W.G., Daroff R.B., Fenichel G.M., and Marsden C.D. (Eds). Neurology in clinical practice. 3rd ed (2000), Butterworth-Heinemann, Boston 1829-1878
7. Lewis D.W. Pediatric migraine. Pediatr Rev 28 (2007) 43-53
8. Lewis D.W., Diamond S., Scott D., and Jones V. Prophylactic treatment of pediatric migraine. Headache 44 (2004) 230-237
9. Lewis D., Ashwal S., Hershey A., Hirtz D., Yonker M., Silberstein S., and American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63 (2004) 2215-2224
10. Akyol A., Kiylioǧlu N., Aydin I., et al. Epidemiology and clinical characteristics of migraine among school children in the Menderes region. Cephalalgia 27 (2007) 781-787
11. Igarashi M., May W.N., and Golden G.S. Pharmacologic treatment of childhood migraine. J Pediatr 102 (1992) 653-657
12. Lewis D.W. Migraine and migraine variants in childhood and adolescents. Semin Pediatr Neurol 2 (1995) 127-143
13. Fidan I., Yüksel S., Ýmir T., Irkeç C., and Aksakal F.N. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171 (2006) 184-188
14. Bruno P.P., Carpino F., Carpino G., and Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 11 (2007) 245-248
15. Kemper R.H., Meijler W.J., Korf J., Korf J., and Ter Horst G.J. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 21 (2001) 549-557
16. Mueller L., Gupta A.K., and Stein T.P. Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache 41 (2001) 129-137
17. Perini F., D'Andrea G., Galloni E., et al. Plasma cytokine levels in migraineurs and controls. Headache 45 (2005) 926-931
18. Zivna H., Zivny P., and Palicka V. Serum leptin concentrations after surgery in young rats. Nutrition 18 (2002) 643-646
19. Hershey A.D., and Winner P.K. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc 105 (2005) 2S-8S Suppl. 2
20. Levinstein B. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of adolescent migraine. Cephalalgia 11 (1991) 122-123
21. Hershey A.D., Powers S.W., Bentti A.L., et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40 (2000) 539-549
22. Rao B.S., Das D.G., Taraknath V.R., and Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India 48 (2000) 223-226
23. Lütschg J., and Vassella F. The treatment of juvenile migraine using flunarizine or propranolol [In German]. Schweiz Med Wochenschr 120 (1990) 1731-1736
24. Castellana M., Carini U., Caprici G., and Mazzochi B. Calcium entry blockers in the treatment of primary headache in childhood: our experience with flunarizine and nimodipine. In: Lanzi G., Balottin U., and Cernibori A. (Eds). Headache in children and adolescents. proceedings of the First International Symposium on Headache in Children and Adolescents, Pavia, Italy,19-20 May 1988 (1989), Elsevier, New York 349-352
25. Hershey A.D., Winner P., Kabbouche M.A., et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 45 (2005) 1288-1297
26. Sriwatanakul K., Kelwie W., Lasagna L., Calimlim J.F., Weis O.F., and Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 34 (1983) 234-239
27. Maunuksela E., Olkkola K.T., and Korpela R. Measurement of pain in children with self-reporting and behavioral assessment. Clin Pharmacol Ther 42 (1987) 137-141
28. Hershey A.D., Powers S.W., Vockell A.L., LeCates S., Kabbouche M.A., and Maynard M.K. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 57 (2001) 2034-2039
29. Pothmann R. Prevention of migraine with flunarizine and acetylsalicylic acid: a double-blind study [In German]. Monatsschr Kinderheilkd 135 (1987) 646-649
30. Olness K., MacDonald J.T., and Uden D.L. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 79 (1987) 593-597
31. Sorge F., and Marano E. Flunarizine v. placebo in childhood migraine: a double-blind study. Cephalalgia 2 (1985) 145-148 5 Suppl
32. Sharma H.S., Cervós-Navarro J., and Dey P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci Res 10 (1991) 211-221
33. Martelletti P., Stirparo G., Morrone S., Rinaldi C., and Giacovazzo M. Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med 75 (1997) 448-453
34. Martelletti P., Stirparo G., Rinaldi C., Frati L., and Giacovazzo M. Disruption of the immunopeptidergic network in dietary migraine. Headache 33 (1993) 524-527
35. Sánchez-del-Rio M., and Reuter U. Migraine aura: new information on underlying mechanisms. Curr Opin Neurol 17 (2004) 289-293
36. Empl M., Sostak P., Riedel M., et al. Decreased sTNF-RI in migraine patients?. Cephalalgia 23 (2003) 55-58
37. Covelli V., Munno I., Pellegrino N.M., et al. Are TNF-α and IL-1β relevant in the pathogenesis of migraine without aura?. Acta Neurol 13 (1991) 205-211
38. Shimomura T., Araga S., Esumi E., and Takahashi K. Decreased serum interleukin-2 level in patients with chronic headache. Headache 31 (1991) 310-313
39. Covelli V., Munno I., Pellegrino N.M., Di Venere A., Jirillo E., and Buscaino G.A. Exaggerated spontaneous release of tumor necrosis factor-α/cachectin in patients with migraine without aura. Acta Neurol (Napoli) 12 (1990) 257-263
40. Munno I., Centonze V., Marinaro M., et al. Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache 38 (1998) 465-467
41. Sarchielli P., Alberti A., Baldi A., et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46 (2006) 200-207
42. van Hilten J.J., Ferrari M.D., Van der Meer J.W., Gijsman H.J., and Looij Jr. B.J. Plasma interleukin-1, tumour necrosis factor and hypothalamic-pituitary-adrenal axis responses during migraine attacks. Cephalalgia 11 (1991) 65-67
43. Rainero I., Grimaldi L.M., Salani G., et al. Association between the tumor necrosis factor-α -308 G/A gene polymorphism and migraine. Neurology 62 (2004) 141-143
44. Skoog T., van't Hooft F.M., Kallin B., et al. A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8 (1999) 1443-1449
45. Poscente M., Brioli G., Lulli P., et al. TNFA gene: the -308 promoter polymorphism in migraine. J Headache Pain 2 (2000) S169-S171 1 Suppl
46. Mazaheri S., Hajilooi M., and Rafiei A. The G-308A promoter variant of the tumor necrosis factor-α gene is associated with migraine without aura. J Neurol 253 (2006) 1589-1593
47. Gallai V., Sarchielli P., Floridi A., Francechini M., Trequatrinin A., and Firenze C. Monocyte function in migraine patients with and without aura. Headache Q 5 (1994) 214-227
48. Theoharides T.C., Kops S.K., Bondy P.K., and Askenase P.W. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol 34 (1985) 1389-1398
49. Fischer M.J., Paulussen J.J., Horbach D.A., et al. Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflamm Res 44 (1995) 92-97
50. Rozen T., and Swidan S.Z. Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47 (2007) 1050-1055
51. Kutlu S., Canpolat S., Sandal S., Ozcan M., Sarsilmaz M., and Kelestimur H. Effects of central and peripheral administration of leptin on pain threshold in rats and mice. Neuro Endocrinol Lett 24 (2003) 193-196
52. Berilgen M.S., Bulut S., Gonen M., Tekatas A., Dag E., and Mungen B. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 25 (2005) 1048-1053